Introduction
The LIGHTLas YAG-V is a premier laser photodisruptor designed for advanced clinical treatments, particularly in vitreolysis. It is recognized for its multi-modality capabilities, enhancing its application in medical procedures.

Specifications
The device is registered under the FDA as LPULSA SYL9000 and under the CE as Lpulsa SYL9000. It complies with several international standards, including IEC/EN 60601-1, IEC/EN 60601-1-2, IEC/EN 60601-2-22, and IEC/EN 60825-1, ensuring its safety and efficacy in clinical settings.

Clinical Applications
The LIGHTLas YAG-V is optimized for advanced clinical treatments, offering precise and effective solutions for vitreolysis. Its multi-modality laser capabilities make it suitable for a range of ophthalmic procedures.

Compliance and Standards
The device adheres to rigorous international standards, ensuring it meets safety and performance requirements. This compliance underscores its reliability and effectiveness in medical applications.

Conclusion
The LIGHTLas YAG-V stands out as a leading laser photodisruptor, offering advanced features and compliance with international standards, making it a valuable tool in clinical treatments.